Peking University People's Hospital: Purpura, Thrombocytopenic, Idiopathic trials

The registry lists 46 Purpura, Thrombocytopenic, Idiopathic studies with Peking University People's Hospital as lead sponsor. 19 are open to participants now and 1 have results posted.

Phase 1 5Phase 2 36Phase 3 3No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• TPO-RA Plus Baricitinib vs. TPO-RA for ITPNot yet recruitingNCT07669675Phase 2
• Atorvastatin Combined With NAC Plus Romiplostim for Management of ITPNot yet recruitingNCT07662525Not applicable
• ATRA for Management of Primary ITPNot yet recruitingNCT07597395Phase 3
• Optimal Dose of Zanubrutinib to Treat Adult Immune ThrombocytopeniaNot yet recruitingNCT07315373Phase 1
• An Exploratory Study of Golidocitinib in Adult Patients With ITPNot yet recruitingNCT07196163Phase 1/2
• Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic StrokeNot yet recruitingNCT07070193
• Longitudinal Observational Study on Immune ThrombocytopeniaNot yet recruitingNCT07068425
• The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)RecruitingNCT07065968Phase 2
• The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaNot yet recruitingNCT07064889Phase 2
• Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITPNot yet recruitingNCT07057778Phase 2
• Longitudinal Cohort of Thrombosis and Hemostasis DiseasesRecruitingNCT06727669
• Prednisone Plus IVIg vs. Prednisone for ITP During PregnancyRecruitingNCT06577909Phase 2
• Teriflunomide for Steroid-resistant/Relapse Immune ThrombocytopeniaRecruitingNCT06190145Phase 2
• The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune ThrombocytopeniaRecruitingNCT06176911Phase 2
• Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune ThrombocytopeniaRecruitingNCT05932524Phase 2
• Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune ThrombocytopeniaRecruitingNCT05852847Phase 2
• Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune ThrombocytopeniaNot yet recruitingNCT05459649Phase 2
• Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune ThrombocytopeniaNot yet recruitingNCT05369377Phase 2
• The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaNot yet recruitingNCT05369364Phase 2
• A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune ThrombocytopeniaStatus unknownNCT04214951Results posted
• Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune ThrombocytopeniaActive, not recruitingNCT07733037Phase 2
• Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune ThrombocytopeniaWithdrawnNCT06176235Phase 2
• IVIg Plus Low Dose rhTPO for ITP in PregnancyStatus unknownNCT05634824Phase 2
• The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05494307Phase 2
• The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05471050Phase 2
• Baricitinib for Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05446831Phase 2
• The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9CompletedNCT05438875Phase 3
• The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05353673Phase 2
• The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in PregnancyStatus unknownNCT05333744Phase 2
• Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05302024Phase 2
• The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05281068Phase 2
• A Study of Zanubrutinib in Patients With ITPCompletedNCT05279872Phase 2
• A Study of Orelabrutinib in Patients With ITPStatus unknownNCT05124028Phase 1/2
• Machine-learning Based Prediction Model in Primary Immune ThrombocytopeniaStatus unknownNCT05116423
• The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaStatus unknownNCT04747080Phase 2
• A Study of ATRA in the Treatment of ITPStatus unknownNCT04618328Phase 2
• Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)Status unknownNCT04518878Phase 1
• Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)Status unknownNCT04516837Phase 2
• The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT04481282Phase 2
• The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITPStatus unknownNCT04368598Phase 2
• The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaCompletedNCT04217148Phase 2
• The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT03460808Phase 1/2
• The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT03304288Phase 2
• Treatment of ITP With Rituximab and / or AccutaneStatus unknownNCT02757196Phase 2
• Thrombocytopenia in Gestational PeriodStatus unknownNCT02751593Phase 2/3
• The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune ThrombocytopeniaCompletedNCT01667263Phase 2